Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis. - Wikidata - thesis-toulmin - TriplyDB

Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.

Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.

http://www.wikidata.org/entity/Q36081391

about

High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.Consensus report of the 2015 Weinman International Conference on Mesothelioma Diagnostic and prognostic biomarkers for malignant mesothelioma: an update.A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma.HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study Biomarkers and prognostic factors for malignant pleural mesothelioma.Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis.Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis.Prognostication and monitoring of mesothelioma using biomarkers: a systematic review.Diagnosis and prognosis-review of biomarkers for mesothelioma.Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.Comparison of statistical methods for detection of serum lipid biomarkers for mesothelioma and asbestos exposure.Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population.Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma.Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review.Biomarkers in malignant pleural mesothelioma: current status and future directions.Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on.

P2860

Q27853357-70BBE527-61EA-4475-BD2F-5CB8B1F502E4 Q27908468-94BA42E6-7DF3-45E4-B673-78004F825DBB Q33890558-9FF0FB84-467C-4E35-A6F1-3F5252F10640 Q36662001-B8DD2363-1568-469F-98D3-371A906F7F57 Q36901529-E1F685DA-9BE9-43F2-9C41-A4A80642EA18 Q37516709-ADA3902F-88D9-42E4-A107-696B8AA4CD89 Q38660038-3BB90356-EF61-49F0-B814-9204CDF36784 Q38987622-76C3DFDF-A215-4EB9-8C34-0E36780C87B5 Q39012195-1EF7A584-EE3F-4BE9-9C81-AD5DDC03027B Q39124644-7C1B1CAA-880F-4405-A5BD-09500DA1916F Q39434249-AA78EC4C-5CD8-4EFF-BFC1-4402EDBAB402 Q39977787-763E7BA3-0833-4FED-8B48-58D2A897AC80 Q40189722-FBD78668-E373-4025-8FE7-1F551236FBD8 Q42728294-1C9437E7-9431-4F9F-9880-E7F068B58AAE Q45824718-343CECAE-B4A4-4EED-9362-D359FD76782D Q47133994-785FBE24-5449-40C5-A90E-8DDCEBD1E3A6 Q52672878-BEE8BC8A-1B6E-4EAC-9279-E44C448788D3 Q52672884-9E63AB1F-1A3B-48DC-8B28-214B9F56880A Q55006991-A73C251C-67BB-4216-952C-9AFE4F2C564A Q55459882-274C47E5-E20D-4672-BEF7-E5C705346ACB

P2860

Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.

http://www.wikidata.org/entity/Q36081391

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Fibulin-3 levels in malignant ...... h prognosis but not diagnosis.

@ast

Fibulin-3 levels in malignant ...... h prognosis but not diagnosis.

@en

type

label

Fibulin-3 levels in malignant ...... h prognosis but not diagnosis.

@ast

Fibulin-3 levels in malignant ...... h prognosis but not diagnosis.

@en

prefLabel

Fibulin-3 levels in malignant ...... h prognosis but not diagnosis.

@ast

Fibulin-3 levels in malignant ...... h prognosis but not diagnosis.

@en

P1433

Q36081391-98691EF0-727E-419C-ABDC-8DF4C2814242

P1476

Q36081391-63DEA0CE-F1AF-4E30-A3A0-9613231FFBED

P2093

Q36081391-0B4A6312-56E7-4016-BBD3-ACFC8A1F9800

Q36081391-0C4037FD-5190-4624-8E80-837539C72521

Q36081391-32E95957-5B7B-454B-A8F0-A04B41675CD2

Q36081391-9AE84CEC-FF80-4374-ACE4-2A192E43AEDB

Q36081391-ACBD9ED6-9EAD-4C20-A369-40B765313E34

Q36081391-AD05D327-4E28-420F-9AC7-A73487FF34C1

Q36081391-AE13650F-9738-4EAF-8A91-F64C905A537A

Q36081391-C11CC717-ABCC-4C7E-8856-53F3F081B44E

Q36081391-CEC00589-E248-4296-974C-E25B4DE6B6BC

Q36081391-EAA7170A-6DF0-40FA-8D27-FC85DD4B259E

P2860

Q36081391-047A472B-7AB1-49F6-8AA5-32B084923ED6

Q36081391-08186C76-06BA-4F44-93C2-EBD36970385B

Q36081391-10948835-B687-4054-B383-84749949A1A4

Q36081391-1520AEDA-43B7-4DB8-8EE4-CEF2A619E252

Q36081391-174BA401-18EB-4609-9DEB-8709D08B5703

Q36081391-24557D16-B54E-4905-8059-9C3E4642CB74

Q36081391-2A58307A-3DBA-4543-8E54-6CBF08F5A73A

Q36081391-3B6D7179-DD20-4A2E-955D-E87154D79393

Q36081391-442E4F14-DAD7-4AB0-A7D9-11465BEA1927

Q36081391-4DF8CB1E-4D81-494F-BBC7-3AA2CC64F1E1

P2888

Q36081391-C47AA373-C70A-4813-9747-DCB3591639E9

P304

Q36081391-B749429F-DAC4-487A-8B66-0C2942E1B832

P31

Q36081391-A8C32574-6CF6-4ECB-9356-B7C8B6CC16B2

P356

Q36081391-93CACA02-A309-4710-BEE3-3552F537A1E4

P407

Q36081391-F9712558-CCDE-4923-8FA3-EF75D22A29D0

P433

Q36081391-C1EA0E61-2710-4AB6-8B63-F7DE79F2C4D6

P478

Q36081391-207D93D5-1E3D-4E91-8F04-EE3DCB714582

P50

Q36081391-061994CB-47F9-4A2E-8CD5-88C7C078B929

Q36081391-1B19CF55-AF65-40F8-937A-4736F3C4ADF7

Q36081391-1BE55809-279E-468B-9386-53E87869690D

Q36081391-1D8E81AA-7A5D-49AE-8CBE-D9766A4CA30C

Q36081391-3CF1F977-887A-4A4D-B908-C962CBBA1828

Q36081391-90C24354-D208-420D-9A92-4AC189A18B8A

Q36081391-917A66F4-ED57-44DB-A550-2CC50252F003

Q36081391-EBA3D60D-A396-4F1C-B405-0D093034A206

Q36081391-FA9A2357-1C1A-4D28-A726-801C5B82CAC4

P577

Q36081391-41005317-A28E-4C56-A636-5AECC4E8C98C

P698

Q36081391-0A1D11E7-2D95-4412-89E6-8D678856CB3D

P932

Q36081391-CA69B582-977D-461B-A9B5-648D4A771AB6

P356

P1433

British Journal of Cancer

P1476

Fibulin-3 levels in malignant ...... h prognosis but not diagnosis.

@en

P2093

Anita Rozsas

http://www.w3.org/2001/XMLSchema#string

Emily Pulford

http://www.w3.org/2001/XMLSchema#string

J James B Edelman

http://www.w3.org/2001/XMLSchema#string

Kim Griggs

http://www.w3.org/2001/XMLSchema#string

Michael P Vallely

http://www.w3.org/2001/XMLSchema#string

Mir Alireza Hoda

http://www.w3.org/2001/XMLSchema#string

Rebecca Hyland

http://www.w3.org/2001/XMLSchema#string

Steven C Kao

http://www.w3.org/2001/XMLSchema#string

Walter Klepetko

http://www.w3.org/2001/XMLSchema#string

Yawen Dong

http://www.w3.org/2001/XMLSchema#string

P2860

Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4

EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells

Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.

Fibulins: a versatile family of extracellular matrix proteins

Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation

Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations

Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion

The case for a global ban on asbestos

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.

Focus on molecules: fibulin-3 (EFEMP1).

P2888

P304

963-969

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2015.286

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Michaela B. Kirschner

Nico van Zandwijk

Thomas Klikovits

Viktoria Laszlo

P577

2015-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26263483

http://www.w3.org/2001/XMLSchema#string

P932

4578085

http://www.w3.org/2001/XMLSchema#string